Our results (statistics provided in Supplementary Table S12, ESM1) find that IL1B, IL6, IL10, IL12B, IL17D, IL18, IL22, CXCL8, CCL4, ACOD1, TLR1, TLR4 and TLR7 show clear distinction between the controls and the MG treatment groups (Figure 3), and at the same time CCL4, TLR1, TLR4, TLR7 show also significant variation in expression between the populations. This evidence concerns the gene IL10 and myasthenia gravis.